Related Articles
Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma
Urine tenascin‑C is an independent risk factor for bladder cancer patients
Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder
Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions
TPS IN SERUM AND URINE OF EGYPTIAN BLADDER-CANCER PATIENTS